We have analyzed matched serum and breast cyst fluid samples for total PSA from 148 patients with fibrocystic breast disease. We have also determined the molecular forms of PSA (free PSA and PSA bound to a 1 -antichymotrypsin) in 78 breast cyst fluid samples. We found that total PSA can be detected
Prostate-specific antigen in breast cyst fluid: Possible role of prostate-specific antigen in hormone-dependent breast cancer
โ Scribed by Leslie C. Lai; Hakan Erbas; Thomas W. J. Lennard; Robert T. Peaston
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 442 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prostatic-specific antigen (PSA) is regarded as a specific marker secreted by normal and neoplastic acinar epithelial cells of the prostate gland; its detection by immunocytochemistry has been accepted as an indication of metastatic prostate cancer. This is ascribed to the commonly held belief that
## Background: Our objective was to evaluate five preclinical prostate cancer (cap) xenograft models to determine whether (1) prostate-specific antigen (psa) formed complexes in murine serum, (2) the percentage of free psa (f-psa) was characteristic of a given xenograft line, and (3) the percentage
Two-dimensional electrophoresis of prostatespecific antigen in sera of men with prostate cancer or benign prostate hyperplasia Prostate-specific antigen (PSA), the main marker for prostate cancer (PCa), is released from the prostate into the blood stream at nanogram level and may increase in PCa and
The characteristic sclerotic appearance of bone metastases from prostate cancer is unexplained but could involve excess peritumoural activity of osteoblast mitogens such as the insulin-like growth factors (IGFs). Since prostatic metastases are distinguished by androgen-dependent secretion of prostat
## BACKGROUND. Although many physicians measure serum prostate specific antigen (PSA) during the follow-up of patients with hormone refractory prostate carcinoma (HRPC), little has been done to formalize the determination of how these serial values of PSA impact on prognosis. To understand HRPC fu